Although innovations in diagnostics and treatment regimens have been successful in reducing death rates and incidence of tuberculosis, the COVID-19 pandemic reversed this trend. In the Microbiology Society Conference 2023 session “Tuberculosis: the forgotten pandemic” exciting research in this area with broad applications beyond mycobacteria will be reviewed. The scope is broad with scientists showcasing cutting-edge tools and highlighting paradigm shifts in our understanding of one of the most successful pathogens on the planet.
Tuberculosis: The forgotten pandemic – 19th April, 10:00, Hall 10
Chaired by Dany Beste, University of Surrey
10:00 – 10:30 Use of a rapid bacteriophage-based assay to detect low level, bacteraemia associated with TB infections in immuno-competent patients – Cath Rees (University of Nottingham, UK)
10:30 – 10:45 Local immune response to Mycobacterium tuberculosis in pulmonary granulomas from experimentally infected rhesus macaques – Laura Hunter (UK-HSA, UK)
10:45 – 11:00 A Galleria mellonella – Mycobacterium tuberculosis H37Rv infection model for virulence gene and anti-tuberculosis drug screening – Masanori Asai (Imperial College London, UK)
11:00 – 11:15 Break
11:15 – 11:30 Modelling Mycobacterial Membranes: Anyone for PIMS? – Chelsea Brown (University of Warwick, UK)
11:30 – 12:00 Friend and foe? Novel cell wall hydrolases in mycobacterial physiology – Sam Benedict (University of Birmingham, UK)
12:00 – 12:15 N-acetylglucosamine-6-phosphate deacetylase (nagA) is essential for peptidoglycan derived amino sugar recycling in mycobacteria – Charlotte Cooper (University of Warwick, UK)
12:15 – 12:30 Host Cell environments and antibiotic efficacy – Maximiliano Gutierrez (The Crick Institute, UK)
Microbiology Society Annual Conference 2023, Birmingham International Convention Centre (The ICC) 8 Centenary Square, Birmingham, B1 2EA.
Find out more and book at microbiologysociety.org/event/annual-conference/annual-conference-2023.html
